Key facts
- Hilo Health’s last known valuation is $45.2M (Jun 2023).
- It has raised $111.8M; the latest was Later Stage VC ($42.0M) in May 2025.
- Notable investors include Khosla Ventures, Verve Ventures, Earlybird Venture Capital, Molten Ventures, KFund — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Hilo Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Hilo Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hilo Health
Developer of a monitoring tool designed to prevent and assist in high blood pressure. The company's tool combines common optical sensors and clinically validated software algorithms to measure an individual's blood pressure at the wrist, enabling patients to understand the underlying causes of blood pressure to develop new approaches to deal with the limiting and life-threatening condition.
- Sector
- Healthcare
- HQ
- Neuchatel, Switzerland
- Founded
- 2018
- Employees
- 76
- Website
- hilo.com/
- Ownership
- Privately Held (backing)
Hilo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hilo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hilo Health in its N-PORT filings yet. We sweep new filings monthly.